‘Personalised Medicines: Can There Ever be a Right of Access?’
Invitation Only Intelligence Exchange
Kindly hosted by Jeremy Lefroy MP
With guest speakers:
Zoë Molyneux, Senior Policy Adviser, Cancer Research UK
Dr Zahid Latif, Head of Health & Care, Innovate UK
Charlotte Phelps, General Manager, Nordic Pharma UK & EMIG Group Member
The event will consider the anticipated growth in the development of personalised medicines for patients and whether these could represent value for the NHS and the taxpayer at large. The NHS constitution currently promises us that we can have access to NICE approved medication, but already local decision making undermines this and the high initial cost of personalised treatment poses a real challenge. Additionally, the smaller the target group for a treatment is, the less likely it is that NICE will assess the drug so it won’t have a HTA ‘mandate’. Medical R&D, as you know, is crucial to our economy, so what are the prospects for innovation and uptake?
- Date
- February 10, 20162016-02-10T04:00:00 - February 10, 2016 2016-02-10T05:30:06
- Time
- 4:00 PM 2016-02-10T04:00:00 - 5:30 PM 2016-02-10T05:30:06
- Location
- Portcullis House, Westminster
